Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.
More in Innovation
6 Best VPN Services (2026), Tested and Reviewed
November 5, 2026
The 7 Best Early Black Friday TV Deals (2026)
November 5, 2026
How Elon Musk and Big Tech Poured Millions Into the Midterms, and Lost
November 5, 2026
Ads in Chatbots Have Arrived. Here’s What’s Working—and What’s Not
November 5, 2026
13 Best Early Black Friday Deals at Best Buy on Hot Tech (2026)
November 5, 2026
The Blue Tsunami Swept Doctors and Scientists Into Office
November 5, 2026
Latest News
Iran’s security chief meets Putin, delivers message from Khamenei
November 6, 2026
Gaza turns discarded cooking pots into seawalls
November 6, 2026
California governor commutes sentences of more than 500 people on death row
November 6, 2026
Major tech stocks plunge as US midterms add to fears of AI slowdown
November 6, 2026
Israeli settlers set fire to Palestinian olive grove near Ramallah
November 6, 2026
Turkiye’s parliament ratifies Mecca defence agreement
November 6, 2026